Jeong, J., Jeon, W., Ahn, S., Kim, Y., Oh, I., Park, C., . . . Chung, W. (2020). Treatment time to the end of thoracic radiotherapy has more predictive power for survival than radiation dose intensity in patients with limited-stage small-cell lung cancer receiving concurrent chemoradiation of more than 45 Gy. Oncol Lett.
Chicago Style CitationJeong, Jae-Uk, et al. "Treatment Time to the End of Thoracic Radiotherapy Has More Predictive Power for Survival Than Radiation Dose Intensity in Patients With Limited-stage Small-cell Lung Cancer Receiving Concurrent Chemoradiation of More Than 45 Gy." Oncol Lett 2020.
Cita MLAJeong, Jae-Uk, et al. "Treatment Time to the End of Thoracic Radiotherapy Has More Predictive Power for Survival Than Radiation Dose Intensity in Patients With Limited-stage Small-cell Lung Cancer Receiving Concurrent Chemoradiation of More Than 45 Gy." Oncol Lett 2020.